To the full analysis
National Health Investors stock: growth
NHINational Health Investors reported $378.53M in revenue for fiscal 2025, up 12.9% on the prior year, up 2.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
5%
per year from 2006 to 2025, per share 2.1%
Earnings (Annual rate)
3.9%
per year from 2006 to 2025, per share 1%
Free cash flow (Annual rate)
7.5%
per year from 2006 to 2025, per share 4.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 2.6% | 5.2% | 5.0% |
| Revenue per share | 1.6% | 2.9% | 2.1% |
| Earnings | −5.1% | −0.5% | 3.9% |
| Earnings per share | 0.0% | −2.6% | 1.0% |
| Free cash flow | −1.0% | 16.0% | 7.5% |
| Free cash flow per share | −2.0% | 13.5% | 4.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $150.72M | $69.23M | $55.31M |
| 2007 | $62.31M | $96.44M | $64.04M |
| 2008 | $63.01M | $57.51M | $63.09M |
| 2009 | $64.22M | $64.23M | −$12.36M |
| 2010 | $78.4M | $69.42M | −$21.19M |
| 2011 | $82.7M | $81.13M | $1.05M |
| 2012 | $96.95M | $90.73M | $86.27M |
| 2013 | $117.83M | $106.18M | −$529.53M |
| 2014 | $177.51M | $101.61M | −$409.63M |
| 2015 | $228.99M | $148.86M | $49.91M |
| 2016 | $248.5M | $151.54M | −$189.8M |
| 2017 | $278.66M | $159.37M | $21.98M |
| 2018 | $294.61M | $154.33M | $60.22M |
| 2019 | $318.08M | $160.46M | $222.96M |
| 2020 | $332.81M | $185.13M | $231.99M |
| 2021 | $298.72M | $111.8M | $210.8M |
| 2022 | $278.19M | $66.4M | $180.71M |
| 2023 | $319.84M | $135.65M | $180.71M |
| 2024 | $335.18M | $137.99M | $192.44M |
| 2025 | $378.53M | $142.18M | $220.26M |
Revenue by segment
How National Health Investors, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Real Estate Investment78%
- Senior Housing Operating Portfolio21%
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| Real Estate Investment | $242.08M | $270.68M | $280.29M | $295.57M | 78.1% |
| Senior Housing Operating Portfolio | $35.8M | $48.81M | $54.42M | $80.06M | 21.2% |
| Total revenue | $278.19M | $319.84M | $335.18M | $378.53M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Jan 2023)
- Valuation signal Undervalued since 11 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.